NEUROFIELDZ INC.

Newton, MA · Medtech · Private

NeuroDotVR, a portable wireless diagnostic system for neuro-visual disorders including macular degeneration

Grants
$5.2M
9 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Novel Electric Field Encephalography Sensors for Neuromonitoring$150,000
Federal grantDepartment of Health and Human Services · Phase I · Neuro-Optical Diagnostic System for Macular Degeneration$225,000
Federal grantDepartment of Health and Human Services · Phase I · Neuro Optical Diagnostic System for Macular Degeneration$225,000
Federal grantDepartment of Health and Human Services · Phase I · Theranostic Virtual Reality Headset for Amblyopia$225,000
Federal grantDepartment of Health and Human Services · Phase II · Neuro-Optical Diagnostic System for Macular Degeneration$961,818
Federal grantDepartment of Health and Human Services · Phase II · Neuro-Optical Diagnostic System for Macular Degeneration$1,976,157
Federal grantDepartment of Health and Human Services · Phase II · Neuro-Optical Diagnostic System for Macular Degeneration$964,339
Federal grantDepartment of Health and Human Services · Phase II · Neuro-Optical Diagnostic System for Macular Degeneration$50,000
Federal grantDepartment of Health and Human Services · Phase I · Objective Mobile diagnostics for Optic Neuropathies$375,940
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2098Monogram Orthopaedics Inc.——
2099GEL4MED, INC.——
2100EXVADE BIOSCIENCE INC——
2101NEUROFIELDZ INC.——
2102AI Viewlife——
2103Phase One Medical, LLC——
2104Digibeat Health Monitoring Systems, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.